## EQR: Equity Residential - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 8.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($59.14)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Equity Residential to Issue Quarterly Dividend of $0.69 (NYSE:EQR)**
- Source: MarketBeat | 20251213T155218 | Somewhat-Bullish | Relevance: 100%
- Equity Residential (NYSE:EQR) has announced a quarterly dividend of $0.6925 per share, payable on January 16th to shareholders of record by January 2nd. Despite a current high payout ratio of 205.2%, analysts anticipate future earnings per share of $4.21, which would comfortably cover the annualized dividend of $2.77. The company currently holds a "Hold" rating from Wall Street analysts with an average target price of $70.02.

**2. Camden Property Trust (CPT): Reassessing Valuation After Q3 Earnings Beat and Upgraded Funds From Operations Guidance**
- Source: Simply Wall Street | 20251214T153902 | Neutral | Relevance: 65%
- Camden Property Trust (CPT) recently released strong Q3 earnings, exceeding expectations and raising its full-year funds from operations guidance. Despite this positive news and reaffirmed dividends, the stock has seen a negative year-to-date return, suggesting a stabilization rather than a surge in sentiment. While narratives suggest CPT is 11% undervalued with a target fair value of $116.67, driven by strong apartment demand and moderating supply, an alternative view highlights its high price-to-earnings ratio compared to peers, suggesting limited room for error if growth falters.

**3. Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)**
- Source: ts2.tech | 20251215T133223 | Somewhat-Bullish | Relevance: 61%
- Kenvue Inc. (NYSE: KVUE) stock is currently trading around $17.3, below the implied value of the Kimberly-Clark acquisition offer of approximately $18.59, reflecting market concerns about the deal's timeline, risks, and ongoing Tylenol litigation. Key factors influencing the stock include the S-4 filing progress, shareholder sentiment, and legal developments, particularly the Texas Attorney General's lawsuit against Johnson & Johnson and Kenvue. Despite the acquisition context, Kenvue's recent operational performance shows a decline in net sales and organic sales, with reaffirmed FY2025 modest outlook.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Barclays | $77 | $80 | -4% |
| 2025-11-24 | Mizuho | $65 | $66 | -2% |
| 2025-11-17 | Truist Securiti | $70 | $75 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Barclays | main | Overweight |
| 2025-11-24 | Mizuho | main | Neutral |
| 2025-11-17 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.1% (+2.3%)
- Blackrock Inc.: 10.2% (+1.1%)
- State Street Corpora: 6.6% (+2.8%)
- Price (T.Rowe) Assoc: 5.2% (-4.5%)
- Apg Asset Management: 3.0% (-0.7%)

### Key Risks

1. Valuation stretched: PEG 8.2x requires aggressive growth execution.
2. Long-term trend broken: trading 7.3% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +3.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 8.15 signals overvaluation risk, limited margin of safety. Forward P/E 42.7x stretched relative to 6% growth. Quality metrics strong (margin 38%). Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.0B |
| Beta | 0.76 |
| 52W Range | $58.38 - $75.86 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.15 |
| Forward P/E | 42.7 |
| Current P/E | 45.3 |
| YoY Growth | 6.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.8% to 0.9% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 52. OFD pattern: -DLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.91% (CS: 43) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.002x | Above |
| vs SMA200 | 0.927x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.10
- **Stop Loss:** $59.14 (3.2% risk)
- **Target:** $63.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 510
- **Position Value:** $31,161.00
- **Portfolio %:** 31.16%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-09 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.42 | $0.37 | -11.5% |
| 2025Q2 | $0.30 | $0.34 | +12.6% |
| 2025Q1 | $0.27 | $0.26 | -4.9% |
| 2024Q4 | $0.40 | $0.26 | -35.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*